Moderna Stock Pops Despite Growing Losses On Massive Sales …

Feb 25, 2021 · Losses widened, but sales skyrocketed over 2019 numbers. Moderna stock has a bullish Relative Strength Rating of 97 out of a best-possible 99, according to IBD Digital. This …

9%
OFF

Moderna's Stock Pops After Surprise Quarterly Profit, Even As …

2 weeks from now

Feb 22, 2024 · Moderna on Thursday also reiterated its 2024 full-year product sales guidance of about $4 billion. Moderna shares have dropped 11.9% in the year to date, while the S&P 500 …

morningstar.com

$13
OFF

Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Nov 7, 2024 · Cambridge, Mass.-based Moderna (MRNA) had a net profit of $13 million, or 3 cents a share, for the quarter, after a loss of $3.6 billion, or $9.53 a share, in the year-earlier …

morningstar.com

17%
OFF

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

2 weeks from now

1 day ago · Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now expects 2025 revenue to come in between $1.5 billion and …

nbcnewyork.com

$0.03
OFF

Moderna EPS Beats Estimates, Sales Rise | The Motley Fool

2 weeks from now

Nov 7, 2024 · Moderna's positive EPS of $0.03 for the quarter significantly surpassed the analyst forecast of a loss of $1.94 per share. This positive result was helped by its latest COVID-19 …

fool.com

$13
OFF

Moderna Reports Surprise Profit On Higher-than-expected COVID …

2 weeks from now

Nov 7, 2024 · Moderna posted a profit of $13 million, or 3 cents a share, for the quarter, compared to a loss of $3.6 billion a year ago. Analysts had expected a loss of $753 million, or $1.90 a …

yahoo.com

69%
OFF

Moderna Stock Pops On Surprise Earnings Beat | Kiplinger

2 weeks from now

May 4, 2023 · Indeed, analysts surveyed by S&P Global Market Intelligence forecast Moderna to post a net loss of $1.75 a share. Total revenue fell 69% to $1.9 billion from $6.1 billion in last …

kiplinger.com

94%
OFF

Moderna Stock Has Lost 94% Of Its Value Over Four Years. Is It A …

2 weeks from now

21 hours ago · Despite a promising move after the CDC put out Covid test news, Moderna stock isn't a buy. In fact, shares were definitively a sell on Jan. 13 when they tumbled below their 50 …

investors.com

$13
OFF

Moderna’s Stock Pops After Biotech Ekes Out A Surprise Profit, And ...

2 weeks from now

Cambridge, Mass.-based Moderna had a net profit of $13 million, or 3 cents a share, for the quarter, after a loss of $3.6 billion, or $9.53 a share, in the year-earlier period. Revenue rose …

msn.com

56%
OFF

Moderna (MRNA) Stock Drops Despite Market Gains: Important

2 weeks from now

Oct 8, 2024 · Moderna (MRNA) closed at $58.39 in the latest trading session, marking a -0.56% move from the prior day. The stock's performance was behind the S&P 500's daily gain of …

nasdaq.com

$2
OFF

Moderna Stock Pops After Covid Shot Obliterates Sales Views

2 weeks from now

May 4, 2022 · Despite a nearly $2 billion sales beat, Moderna restated its prediction for $21 billion in full-year advance purchase agreements for its two-shot Covid vaccine. The projection was …

investors.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · On Sept. 12, management issued fresh sales guidance for the full year 2025 and also revised the previously issued sales outlook for 2028. Moderna expects to generate …

yahoo.com

4%
OFF

Moderna Stock Crash Intensifies: Losses Top $130 Billion After ...

2 weeks from now

Jan 22, 2022 · KEY FACTS. Moderna stock fell 4.4% Friday to an eight-month low of $160, pushing shares down more than 20% over the past week amid growing research suggesting …

forbesafrica.com

87%
OFF

Moderna (MRNA) Stock Declines 87% In Three Years: 3 Key Points

2 weeks from now

Nov 28, 2024 · On November 30th, exactly 3 years ago, Moderna’s (MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced at $43.50. This downturn …

nasdaq.com

21%
OFF

Moderna’s Stock Slides 21% After Company Lowers Full-year Sales ...

2 weeks from now

Aug 1, 2024 · Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue …

marketwatch.com

FAQs about Moderna Stock Pops Despite Growing Losses On Massive Sales … Coupon?

Why did Moderna stock jump 10% early?

Moderna Inc.’s stock jumped 10% early Thursday, after the company’s third-quarter earnings showed a surprise profit and revenue that beat estimates by a wide margin. Cambridge, Mass.-based Moderna had a net profit of $13 million, or 3 cents a share, for the quarter, after a loss of $3.6 billion, or $9.53 a share, in the year-earlier period. ...

Why did Moderna stock fall 21%?

Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. It was the stock’s biggest-ever one-day decline and has erased all of its gains for the year to date. Already a subscriber? ...

Is Moderna a good stock to buy?

Photo: joel saget/Agence France-Presse/Getty Images Moderna Inc.’s stock was higher but off its early highs Thursday, after the company’s third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. ...

Why did Moderna's stock tumble 21% Thursday?

Moderna’s stock was slammed early Thursday after it cut its sales guidance. Photo: POOL/AFP via Getty Images Moderna Inc.’s stock tumbled 21% Thursday, after the biotech company cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter loss and revenue that topped estimates. ...

How many analysts downgraded Moderna stock on Thursday?

Five analysts out of 25 downgraded Moderna stock on Thursday, according to FactSet. And 14 cut their price targets on shares. Moderna stock tumbled 2% to 68.28 on Friday. That followed a 12.4% dive on Thursday. It's not the first time Moderna's financial outlook has weighed on shares, William Blair analyst Myles Minter said. ...

Why is Moderna stock tumbling in 2024?

Weak adoption of Moderna’s respiratory syncytial virus (RSV) vaccine has exacerbated financial pressures, with the product contributing "minimal sales" in 2024. The announcement sent Moderna shares tumbling by 19 percent to $34.07 in early trading. ...